Segal J, Ingbar S H
J Clin Invest. 1985 Oct;76(4):1575-80. doi: 10.1172/JCI112139.
In previous studies we have demonstrated that 3,5,3'-triiodothyronine (T3) in vitro produces a prompt increase in the uptake of the sugar analogue 2-deoxyglucose (2-DG) by freshly isolated rat thymocytes. This effect is prompt, being evident at 20 min after addition of T3, is independent of new protein synthesis, and can be elicited by physiologic concentrations of the hormone. In the present studies, we have sought to determine whether physiologic doses of T3 are capable of inducing an increase in 2-DG uptake in the thymocytes of the living animal. Therefore, 26-28-d-old female rats were injected with increasing doses of i.v. T3, followed 60 min later by 3H-labeled 2-DG. 30 min later, animals were killed, thymocytes were isolated, and their 3H content determined. Uptake of [3H]2-DG was increased by T3 in a dose-dependent manner. The lowest effective dose was 10 ng/100 g of body weight (30% above control) and the maximally effective dose 1 microgram/100 g of body weight (116% above control). The effect of T3 was independent of new protein synthesis in that it was not blocked by a dose of cycloheximide that inhibited the incorporation of [3H]leucine into thymocyte protein by 92-95%. Comparable studies with various thyronine analogues revealed the following rank order of potency: L-T3 greater than L-3,5,3'5'-tetraiodothyronine (L-T4) greater than D-T3 greater than or equal to D-T4 greater than L-3,3'5'-triiodothyronine greater than 3'-isopropyl-3,5-L-diiodothyronine (T2) = 3,5-L-T2. DL-thyronine was without effect. These studies indicate that T3 in physiologic doses acts in vivo to increase the uptake of sugar by rat thymocytes by a mechanism that is extranuclear in origin, in that it is independent of new protein synthesis. The findings support the conclusion that the previously demonstrated effects of T3 on thymocyte sugar uptake in vitro, which seem clearly to be mediated at the level of the plasma membrane, have physiologic relevance.
在先前的研究中,我们已经证明,体外培养时,3,5,3'-三碘甲状腺原氨酸(T3)可使新鲜分离的大鼠胸腺细胞对糖类似物2-脱氧葡萄糖(2-DG)的摄取迅速增加。这种效应迅速出现,在添加T3后20分钟即可明显观察到,且不依赖于新蛋白质的合成,生理浓度的该激素即可引发此效应。在本研究中,我们试图确定生理剂量的T3是否能够诱导活体动物胸腺细胞对2-DG的摄取增加。因此,给26 - 28日龄的雌性大鼠静脉注射递增剂量的T3,60分钟后再注射3H标记的2-DG。30分钟后,处死动物,分离胸腺细胞,并测定其3H含量。T3可使[3H]2-DG的摄取呈剂量依赖性增加。最低有效剂量为10 ng/100 g体重(比对照组高30%),最大有效剂量为1 μg/100 g体重(比对照组高116%)。T3的作用不依赖于新蛋白质的合成,因为抑制[3H]亮氨酸掺入胸腺细胞蛋白质达92 - 95%的环己酰亚胺剂量并不能阻断T3的作用。对各种甲状腺素类似物的类似研究显示出以下效价顺序:L-T3大于L-3,5,3'5'-四碘甲状腺原氨酸(L-T4)大于D-T3大于或等于D-T4大于L-3,3'5'-三碘甲状腺原氨酸大于3'-异丙基-3,5-L-二碘甲状腺原氨酸(T2) = 3,5-L-T2。DL-甲状腺素无作用。这些研究表明,生理剂量的T3在体内通过一种源于细胞核外的机制发挥作用,增加大鼠胸腺细胞对糖的摄取,因为它不依赖于新蛋白质的合成。这些发现支持以下结论:先前证明的T3对体外胸腺细胞糖摄取的作用,显然是在质膜水平介导的,具有生理相关性。